Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2009-07-07 - 2009-07-21
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP-study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
yes
Remarks:
Relative humidity in the animal room was between 45-100% for few hours.
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
Spinel (Mg(AlO2)2)
EC Number:
215-105-9
EC Name:
Spinel (Mg(AlO2)2)
Cas Number:
1302-67-6
Molecular formula:
AlO2.1/2Mg
IUPAC Name:
magnesium dialuminium oxide
Details on test material:
Batch no.: SP-AR78-20MY, batch 0825193518
Purity: > 99%
Expiration date: unlimited stability

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female

Study design: in vivo (LLNA)

Vehicle:
dimethylformamide
Concentration:
10, 25, 50 %
No. of animals per dose:
4
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)

Results and discussion

Positive control results:
Experiment performed in June 2009.
Positive control substance: alpha-Hexylcinnamaldehyde
Vehicle: acetone:olive oil (4+1)
Test item concentration % (w/v) Group Measurement DPM DPM-BG a) number of lymph nodes DPM per lymph node b) S.I.
--- BG I 23 --- --- --- ---
--- BG II 19 --- --- --- ---
0 1 5842 5821 8 727.6
5 2 10450 10429 8 1303.6 1.79
10 3 12168 12147 8 1518.4 2.09
25 4 39834 39813 8 4976.6 6.84

BG = Background (1 ml 5% trichloroacetic acid) in duplicate
1 = Control Group
2-4 = Test Group
S.I. = Stimulation Index
a) = The mean value was taken from the figures BG I and BG II
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Remarks on result:
other: 10 %: 1.17 25 %: 1.88 50%: 1.42
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: see Remark
Remarks:
Test item concentration % (w/w) Group Measurement DPM DPM-BGa) number of lymph nodes DPM per lymph nodeb) S.I. --- BG I 29 --- --- --- --- --- BG II 26 --- --- --- --- --- 1 4932 4905 8 613.1 10 2 5770 5743 8 717.8 1.17 25 3 9240 9213 8 1151.6 1.88 50 4 6996 6969 8 871.1 1.42 BG = Background (1 ml 5% trichloroacetic acid) in duplicate 1 = Control Group 2-4 = Test Group S.I. = Stimulation Index a) = The mean value was taken from the figures BG I and BG II b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled The EC3 value could not be calculated, since all S.I.´s are below 3.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
The test item Spinel was not a skin sensitiser under the described conditions.
Executive summary:

In order to study a possible contact allergenic potential of Spinel, three groups each of four female mice were treated daily with the test item at concentrations of 10, 25, and 50% (w/w) in dimethylformamide by topical application to the dorsum of each ear lobe (left and right) for three consecutive days. A control group of four mice was treated with the vehicle (dimethylformamide) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in ab-scintillation counter.

All treated animals survived the scheduled study period and no signs of toxicity were observed.

A test item is regarded as a sensitiser in the LLNA if the exposure to one or more test concentration resulted in 3-fold or greater increase in incorporation of 3HTdR compared with concurrent controls, as indicated by the Stimulation Index (S.I.). The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.

In this study Stimulation Indices of 1.17, 1.88, and 1.42 were determined with the test item at concentrations of 10, 25, and 50% in dimethylformamide. The EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.